Chikungunya natural history, complications and prognosis: Difference between revisions
Jump to navigation
Jump to search
Line 12: | Line 12: | ||
==References== | ==References== | ||
* [http://www.cdc.gov/Chikungunya/index.html CDC Chikungunya virus] | |||
{{Reflist|2}} | {{Reflist|2}} | ||
Revision as of 15:36, 8 June 2014
Chikungunya Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Chikungunya natural history, complications and prognosis On the Web |
American Roentgen Ray Society Images of Chikungunya natural history, complications and prognosis |
FDA on Chikungunya natural history, complications and prognosis |
CDC on Chikungunya natural history, complications and prognosis |
Chikungunya natural history, complications and prognosis in the news |
Blogs on Chikungunya natural history, complications and prognosis |
Risk calculators and risk factors for Chikungunya natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Alejandro Lemor, M.D. [2], Alonso Alvarado, M.D. [3]
Overview
- Rare complications include uveitis, retinitis, myocarditis, hepatitis, nephritis, bullous skin lesions, hemorrhage, meningoencephalitis, myelitis, Guillain-Barré syndrome, and cranial nerve palsies.
- Persons at risk for severe disease include neonates exposed intrapartum, older adults (e.g., > 65 years), and persons with underlying medical conditions (e.g., hypertension, diabetes, or cardiovascular disease).
- Some patients might have relapse of rheumatologic symptoms (e.g., polyarthralgia, polyarthritis, tenosynovitis) in the months following acute illness.
- Studies report variable proportions of patients with persistent joint pains for months to years.
- Mortality is rare and occurs mostly in older adults.